Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Kimco Realty
KIM
$16.4B
| $23.2M | 0.01% |
1,174,245
+406,840
| +53% | +$9.35M |
|
|
ITCI
1627
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $23.2M | 0.01% |
405,731
-193,301
| -32% | -$11M |
|
1628
Teck Resources
TECK
$31.2B
| $23.1M | 0.01% |
756,652
-1,462,540
| -66% | -$57.7M |
|
1629
Ryder
R
$10.1B
| $23.1M | 0.01% |
325,430
+155,691
| +92% | +$11.4M |
|
1630
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$2.12B
| $23.1M | 0.01% |
806,074
-236,784
| -23% | -$7.13M |
|
1631
PUT
Royal Gold
RGLD
$19.5B
| $23.1M | 0.01% |
216,400
-4,100
| -2% | -$507K |
|
1632
Booz Allen Hamilton
BAH
$9.32B
| $23.1M | 0.01% |
255,113
+63,945
| +33% | +$5.46M |
|
1633
TD Synnex
SNX
$20.7B
| $23M | 0.01% |
252,928
+83,257
| +49% | +$8.27M |
|
1634
International Bancshares
IBOC
$4.56B
| $23M | 0.01% |
573,561
+47,758
| +9% | +$1.95M |
|
1635
DoubleVerify
DV
$2.04B
| $23M | 0.01% |
1,013,907
+356,630
| +54% | +$8.02M |
|
1636
Toronto Dominion Bank
TD
$205B
| $23M | 0.01% |
350,395
+203,549
| +139% | +$14.8M |
|
1637
CALL
Idexx Laboratories
IDXX
$43.4B
| $23M | 0.01% |
65,500
+10,600
| +19% | +$4.32M |
|
1638
T. Rowe Price
TROW
$23.6B
| $23M | 0.01% |
202,196
+16,101
| +9% | +$2.05M |
|
1639
Saic
SAIC
$5.36B
| $23M | 0.01% |
246,666
+194,633
| +374% | +$17M |
|
1640
Flowers Foods
FLO
$1.59B
| $23M | 0.01% |
872,388
+332,825
| +62% | +$8.76M |
|
1641
PUT
iShares Russell 1000 Growth ETF
IWF
$128B
| $22.9M | 0.01% |
419,600
-364,800
| -47% | -$21.9M |
|
1642
PUT
Vanguard Information Technology ETF
VGT
$150B
| $22.9M | 0.01% |
561,600
+309,600
| +123% | +$13.9M |
|
1643
BOK Financial
BOKF
$8.88B
| $22.9M | 0.01% |
302,937
+237,549
| +363% | +$20M |
|
1644
Nu Holdings
NU
$73.6B
| $22.8M | 0.01% |
6,108,431
+5,259,549
| +620% | +$26.7M |
|
1645
CALL
Coupang
CPNG
$29B
| $22.8M | 0.01% |
1,791,400
+207,300
| +13% | +$2.83M |
|
1646
Fidelity National Information Services
FIS
$22.1B
| $22.8M | 0.01% |
249,012
-1,234,534
| -83% | -$123M |
|
|
1647
PUT
T. Rowe Price
TROW
$23.6B
| $22.8M | 0.01% |
200,300
+105,000
| +110% | +$13.3M |
|
1648
CALL
Monster Beverage
MNST
$91.7B
| $22.7M | 0.01% |
981,600
+121,200
| +14% | +$2.64M |
|
1649
CALL
Corning
GLW
$143B
| $22.7M | 0.01% |
721,300
+144,100
| +25% | +$4.97M |
|
|
CTRA
1650
CALL
DELISTED
Coterra Energy
CTRA
| $22.7M | 0.01% |
880,000
+43,600
| +5% | +$1.32M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.